Tech Company Financing Transactions
Morphoceuticals Funding Round
Morphoceuticals secured a $8 million Seed funding round on 2/15/2023. Investors included Juvenescence and Prime Movers Lab.
Transaction Overview
Company Name
Announced On
2/15/2023
Transaction Type
Venture Equity
Amount
$8,000,000
Round
Seed
Investors
Juvenescence (Lead Investor)
Prime Movers Lab (Lead Investor)
Proceeds Purpose
The company intends to use the funds to expand operations and its development efforts.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
Undisclosed
Marblehead, MA 01945
USA
Marblehead, MA 01945
USA
Phone
Undisclosed
Website
Email Address
Overview
Operator of a biotechnology platform intended to establish a basis for limb regeneration and the discovery of novel regenerative interventions. The company focuses on the understanding of the biophysical mechanisms that implement decision-making during complex pattern regulation and uses bioelectric dynamics to change developmental patterning and spur regeneration in organisms that do not regenerate tissues or organs, enabling medical researchers to treat complicated health states and improve amputation stump health, promoting organ regeneration and the treatment of channelopathies.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Michael Hufford
Co-Founder
David Kaplan
Browse more venture capital transactions:
Prev: 2/15/2023: Capsule venture capital transaction
Next: 2/15/2023: Spiffy venture capital transaction
Share this article
About Our Venture Capital Transactions Database
We document every notable VC transaction. VC investment data records reported here are sourced from news reports and company announcements. The data is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs